Levi A Garraway

USPTO Granted Patents = 15 (Patent Applications = 19)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 10)

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 57(Granted Patents)

Location History:

Newton, MA (US) (2011 - 2023)
Boston, MA (US) (2024)

Company Filing History:

15 out of 1,206

Dana-farber-cancer Institute Inc.

patents

4 out of 443

The Broad Institute, Inc.

patents

2 out of 8,369

Massachusetts Institute of Technology

patents

4. 1 out of 1,370

The Brigham and Women's Hospital, Inc.

Massachusetts Eye and Ear Infirmary

patents

7. 1 out of 1,860

University of Pittsburgh

patents

8. 1 out of 14

Instituto Carlos Slim De La Salud, A.c.

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12146196 - C-RAF mutants that confer resistance to RAF inhibitors (2024-11-19),

2. 11963966 - Compositions and methods for treating ovarian tumors (2024-04-23),

3. 11789022 - MEK1 mutation conferring resistance to RAF and MEK inhibitors (2023-10-17),

4. 11788151 - C-RAF mutants that confer resistance to RAF inhibitors (2023-10-17),

5. 11186874 - ERK1 and ERK2 mutations that confer resistance to MAPK pathway inhibitors (2021-11-30),

6. 11078540 - Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy (2021-08-03),

7. 10968484 - Methods of identifying responses to map kinase inhibition therapy (2021-04-06),

8. 10788496 - MEK1 mutation conferring resistance to RAF and MEK inhibitors (2020-09-29),

9. 9880169 - MEK1 mutation conferring resistance to RAF and MEK inhibitors (2018-01-30),

10. 9629839 - C-RAF mutants that confer resistance to RAF inhibitors (2017-04-25),

11. 9370551 - Compositions and methods of treating head and neck cancer (2016-06-21),

12. 9279144 - Screening method for BRAF inhibitors (2016-03-08),

13. 9084781 - MEK mutations conferring resistance to MEK inhibitors (2015-07-21),

14. 8637246 - BRAF mutations conferring resistance to BRAF inhibitors (2014-01-28),

15. 7981609 - Methods for identifying and using SNP panels (2011-07-19),

Title: Inventor Levi A. Garraway - Pioneering Innovations in Newton, MA

Introduction: Levi A. Garraway is a talented inventor based in Newton, MA, known for her groundbreaking contributions to the field of biotechnology and medical research.

Latest Patents: Levi A. Garraway holds several patents related to novel cancer therapies and precision medicine technologies, showcasing her commitment to advancing healthcare solutions.

Career Highlights: With a background in oncology and genetics, Levi A. Garraway has held key positions in renowned research institutions and biopharmaceutical companies, driving forward cutting-edge projects in the fight against cancer.

Collaborations: Throughout her career, Levi A. Garraway has collaborated with leading scientists, medical professionals, and industry experts to bring innovative ideas from the lab to the market, fostering a culture of collaboration and excellence.

Conclusion: Levi A. Garraway's dedication to pushing the boundaries of science and medicine has solidified her reputation as a visionary inventor, shaping the future of healthcare with her transformative innovations.

This text is generated by artificial intelligence and may not be accurate.